2025 年全球关节痛注射市场报告

预计未来几年关节痛注射剂的市场规模将快速成长。到 2029 年，这一数字将成长至 98.1 亿美元，复合年增长率为 12.3%。预测期内的成长可归因于远端医疗服务的扩展、个人化疼痛管理、病患教育和赋权、永续的医疗保健实践和营养支持。预测期内的主要趋势包括再生医学、个人化疼痛管理、创新註射材料、復健技术和人工智慧（AI）增强注射。

关节炎和肌肉骨骼疾病的盛行率不断上升预计将推动关节痛注射市场的成长。肌肉骨骼疾病是全球范围内导致残疾的主要原因，其中腰痛被确定为 160 个国家中最常见的残疾原因。疼痛患者经常接受注射来缓解疼痛和控制发炎。例如，2023年6月，澳洲政府机构澳洲健康与福利研究所报告称，类风湿性关节炎占总疾病负担的2.0%，占与肌肉骨骼疾病相关的总疾病负担的16%。 2022年死亡人数为1,322人，相当于每10万人口5.1人死亡，占全部死亡人数的0.7%。因此，关节炎和肌肉骨骼疾病盛行率的上升推动了关节痛注射市场的发展。

慢性疼痛盛行率的上升预计将推动关节痛注射市场未来的成长。慢性疼痛的特征是长时间持续或持久的不适，一般定义为持续至少 3-6 个月或超过预期的癒合期。关节痛注射通常用于治疗慢性疼痛，尤其是与肌肉骨骼疾病（如骨关节炎、类风湿性关节炎和其他关节相关疾病）相关的慢性疼痛。例如，2022年9月，世界卫生组织（WHO）在其2022年重点报告中报告，非传染性疾病（NCD）或慢性病导致4,100万人死亡，占全球整体的74%。因此，慢性疼痛发生率的不断增加正在推动关节痛注射市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球关节痛注射PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球关节疼痛注射市场成长率分析
• 全球关节痛注射市场表现：规模与成长，2019 年至 2024 年
• 全球关节痛注射市场预测：规模与成长，2024-2029 年，2034 年
• 全球关节痛注射剂总目标市场 (TAM)

第六章 市场细分

• 全球关节痛注射市场：按註射类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 类固醇关节注射
• 玻尿酸注射
• 富血小板血浆 (PRP) 注射
• 胎盘组织基质（PTM）注射
• 其他类型注射
• 全球关节痛注射市场：按关节类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
• 髋关节
• 膝盖和脚踝
• 肩膀和肘部
• 脊椎椎间关节
• 其他关节类型
• 全球关节痛注射市场：依通路、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 医院药房
• 零售药局
• 网路药局
• 全球关节痛注射市场：类固醇关节注射细分市场、注射类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 皮质类固醇注射
• 联合类固醇注射
• 全球关节痛注射市场：透明质酸注射细分市场、注射类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 单剂量透明质酸注射
• 多次注射玻尿酸
• 全球关节痛注射市场：富血小板血浆 (PRP) 注射细分、注射剂类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 自体 PRP 注射
• 同种异体 PRP 注射
• 全球关节痛注射市场：胎盘组织基质 (PTM) 注射细分市场、注射类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 羊水注射
• 胎盘细胞注射
• 全球关节痛注射市场：依其他类型注射细分，依注射类型细分，实际及预测，2019-2024 年，2024-2029F，2034F
• 骨髓抽吸浓缩液（BMAC）注射
• 干细胞注射
• 基因改造细胞注射

第七章 区域和国家分析

• 全球关节痛注射市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球关节痛注射市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 关节痛注射市场：竞争格局
• 关节痛注射市场：公司简介
  • Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Abbvie Inc.
• Bioventus Inc.
• Eli Lilly and Company
• Ferring Pharmaceuticals Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Limited
• Johnson & Johnson Services Ltd.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Novartis AG
• AstraZeneca plc
• Roche Holding AG
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Takeda Pharmaceutical Company Limited

第 32 章 全球竞争基准化分析与仪錶板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 关节痛注射市场 2029-提供最多新机会的国家
• 关节痛注射市场 2029-提供最多新机会的市场
• 关节痛注射市场 2029-成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The joint pain injections market research report is one of a series of new reports from The Business Research Company that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown rapidly in recent years. It will grow from $5.6 billion in 2024 to $6.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $9.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.

The increasing prevalence of arthritis and musculoskeletal disorders is expected to drive the growth of the joint pain injections market. Musculoskeletal disorders are the leading cause of disability globally, with low back pain identified as the most common cause of impairment in 160 countries. Patients often seek injections for pain relief and to manage inflammatory conditions. For example, in June 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the overall burden of disease related to musculoskeletal conditions. In 2022, it resulted in 1,322 deaths, equating to 5.1 deaths per 100,000 people, which represented 0.7% of all deaths. Therefore, the rising prevalence of arthritis and musculoskeletal disorders is driving the joint pain injections market.

The rising incidence of chronic pain is anticipated to drive the growth of the joint pain injections market in the future. Chronic pain is characterized by persistent or long-lasting discomfort that continues for an extended duration, typically defined as lasting at least three to six months or beyond the expected healing time. Joint pain injections are commonly utilized to manage chronic pain, particularly when it is linked to musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, or other joint-related issues. For example, in September 2022, the World Health Organization (WHO) reported in its 2022 Highlights that there were 41 million deaths, accounting for 74% of all fatalities due to noncommunicable diseases (NCDs) or chronic diseases globally each year. Consequently, the increase in the incidence of chronic pain is propelling the growth of the joint pain injections market.

A prominent trend in the joint pain injections market is the focus on new product development. Major companies in this sector are actively engaged in innovating new products to meet consumer demand and enhance their market position. For instance, Contura International Ltd., a UK-based manufacturer of therapeutic hydrogels, introduced Arthrosamid in September 2021. Arthrosamid, an innovative hydrogel injection for knee osteoarthritis, utilizes non-biodegradable hydrogel technology, providing a potent, long-lasting, secure, and minimally intrusive treatment for knee osteoarthritis pain.

Leading companies in the joint pain injections market are concentrating on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is a type of drug delivery system designed to deliver a specific dose of medication in a single injection, offering sustained therapeutic effects over an extended period without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, introduced Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. The product aims to capture a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it demonstrates innovation in meeting patient needs, focusing on providing effective relief with minimal administration effort.

In November 2022, Biocon Biologics Limited, a pharmaceutical company based in India, acquired the biosimilars business from Viatris Inc. for $3.33 billion. This acquisition enables Biocon to utilize Viatris' extensive experience and established presence in the global market, improving access to critical therapies for patients around the world. This strategic move is anticipated to enhance its biosimilars portfolio, including Adalimumab BS for subcutaneous injection, which is indicated for immune-related diseases like rheumatoid arthritis. Viatris Inc. is a healthcare company based in the US that offers joint pain medications.

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Joint Pain Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for joint pain injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The joint pain injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections; Platelet-Rich Plasma (PRP) Injections; Placental Tissue Matrix (PTM) Injections; Other Type Of Injections
• 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types
• 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Steroid Joint Injection: Corticosteroid Injections; Combination Steroid Injections
• 2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections; Multi-Dose Hyaluronic Acid Injections
• 3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections; Allogeneic PRP Injections
• 4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections; Placental Derived Cell Injections
• 5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections; Stem Cell Injections; Genetically Engineered Cell Injections
• Companies Mentioned: Seikagaku Corporation; Flexion Therapeutics Inc.; Zimmer Biomet Holdings Inc.; Sanofi S.A.; Anika Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Joint Pain Injections Market Characteristics

3. Joint Pain Injections Market Trends And Strategies

4. Joint Pain Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Joint Pain Injections Growth Analysis And Strategic Analysis Framework

• 5.1. Global Joint Pain Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Joint Pain Injections Market Growth Rate Analysis
• 5.4. Global Joint Pain Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Joint Pain Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Joint Pain Injections Total Addressable Market (TAM)

6. Joint Pain Injections Market Segmentation

• 6.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroid Joint Injection
• Hyaluronic Acid Injections
• Platelet-Rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Type Of Injection
• 6.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hip Joint
• Knee And Ankle
• Shoulder And Elbow
• Facet Joints Of The Spine
• Other Joint Types
• 6.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Joint Pain Injections Market, Sub-Segmentation Of Steroid Joint Injection, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid Injections
• Combination Steroid Injections
• 6.5. Global Joint Pain Injections Market, Sub-Segmentation Of Hyaluronic Acid Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Hyaluronic Acid Injections
• Multi-Dose Hyaluronic Acid Injections
• 6.6. Global Joint Pain Injections Market, Sub-Segmentation Of Platelet-Rich Plasma (PRP) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous PRP Injections
• Allogeneic PRP Injections
• 6.7. Global Joint Pain Injections Market, Sub-Segmentation Of Placental Tissue Matrix (PTM) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amniotic Fluid Injections
• Placental Derived Cell Injections
• 6.8. Global Joint Pain Injections Market, Sub-Segmentation Of Other Types of Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow Aspirate Concentrate (BMAC) Injections
• Stem Cell Injections
• Genetically Engineered Cell Injections

7. Joint Pain Injections Market Regional And Country Analysis

• 7.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Joint Pain Injections Market

• 8.1. Asia-Pacific Joint Pain Injections Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Joint Pain Injections Market

• 9.1. China Joint Pain Injections Market Overview
• 9.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Joint Pain Injections Market

• 10.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Joint Pain Injections Market

• 11.1. Japan Joint Pain Injections Market Overview
• 11.2. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Joint Pain Injections Market

• 12.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Joint Pain Injections Market

• 13.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Joint Pain Injections Market

• 14.1. South Korea Joint Pain Injections Market Overview
• 14.2. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Joint Pain Injections Market

• 15.1. Western Europe Joint Pain Injections Market Overview
• 15.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Joint Pain Injections Market

• 16.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Joint Pain Injections Market

• 17.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Joint Pain Injections Market

• 18.1. France Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Joint Pain Injections Market

• 19.1. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Joint Pain Injections Market

• 20.1. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Joint Pain Injections Market

• 21.1. Eastern Europe Joint Pain Injections Market Overview
• 21.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Joint Pain Injections Market

• 22.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Joint Pain Injections Market

• 23.1. North America Joint Pain Injections Market Overview
• 23.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Joint Pain Injections Market

• 24.1. USA Joint Pain Injections Market Overview
• 24.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Joint Pain Injections Market

• 25.1. Canada Joint Pain Injections Market Overview
• 25.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Joint Pain Injections Market

• 26.1. South America Joint Pain Injections Market Overview
• 26.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Joint Pain Injections Market

• 27.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Joint Pain Injections Market

• 28.1. Middle East Joint Pain Injections Market Overview
• 28.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Joint Pain Injections Market

• 29.1. Africa Joint Pain Injections Market Overview
• 29.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Joint Pain Injections Market Competitive Landscape And Company Profiles

• 30.1. Joint Pain Injections Market Competitive Landscape
• 30.2. Joint Pain Injections Market Company Profiles
  • 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Joint Pain Injections Market Other Major And Innovative Companies

• 31.1. Abbvie Inc.
• 31.2. Bioventus Inc.
• 31.3. Eli Lilly and Company
• 31.4. Ferring Pharmaceuticals Inc.
• 31.5. Pfizer Inc.
• 31.6. Teva Pharmaceutical Industries Limited
• 31.7. Johnson & Johnson Services Ltd.
• 31.8. Merck & Co. Inc.
• 31.9. GlaxoSmithKline plc
• 31.10. Novartis AG
• 31.11. AstraZeneca plc
• 31.12. Roche Holding AG
• 31.13. Bristol-Myers Squibb Company
• 31.14. Boehringer Ingelheim International GmbH
• 31.15. Takeda Pharmaceutical Company Limited

32. Global Joint Pain Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Joint Pain Injections Market

34. Recent Developments In The Joint Pain Injections Market

35. Joint Pain Injections Market High Potential Countries, Segments and Strategies

• 35.1 Joint Pain Injections Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Joint Pain Injections Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Joint Pain Injections Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer